{"id":15982,"date":"2025-11-23T17:05:44","date_gmt":"2025-11-23T17:05:44","guid":{"rendered":"https:\/\/ugandaupdatenews.com\/?p=15982"},"modified":"2025-11-25T17:10:44","modified_gmt":"2025-11-25T17:10:44","slug":"president-museveni-launches-dei-biopharma-advanced-biotech-park-in-kamuli","status":"publish","type":"post","link":"https:\/\/prowebinhost.com\/anzu\/president-museveni-launches-dei-biopharma-advanced-biotech-park-in-kamuli\/","title":{"rendered":"President Museveni Launches Dei Biopharma Advanced Biotech Park In Kamuli"},"content":{"rendered":"\n

By Our Reporters <\/strong><\/p>\n\n\n\n

in Kamuli<\/strong><\/p>\n\n\n\n

President Yoweri Museveni on November 20, 2025, commissioned a $50 million (Shs180.49 billion) starch factory in Namasagali Sub-county, Kamuli District.<\/p>\n\n\n\n

The factory, owned by Dr Matthias Magoola, founder of Dei Biopharma, will produce starch, glucose, and maltose for pharmaceutical and food industries. It plans to extract more than 100 derivatives from cassava, maize, and potatoes. The facility will require 500 metric tonnes of cassava daily.<\/p>\n\n\n\n

This project forms part of a larger $10 billion investment plan to establish a biotech hub, including a 1,000-bed hospital for sickle cell and cancer treatment, and a vaccine facility.
President Museveni, who has supported Dr Magoola\u2019s pharmaceutical ventures financially, praised the entrepreneur\u2019s innovation.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u201cI met this young man through his uncle, and I helped him when he had issues with India. I facilitated his legal work, and now we appreciate his innovation and should support him,\u201d President Museveni said.<\/p>\n\n\n\n

He encouraged Dr Magoola to forgive critics, adding: \u201cI don\u2019t know why Africans don\u2019t like innovation; they are used to sleeping. Africans like to criticise. Congratulations, Magoola, but forgive everyone disturbing you. That\u2019s how I also started fighting, and people thought I was mad.\u201d<\/p>\n\n\n\n

President Museveni highlighted the importance of industrialisation, noting that industries employ 1.3 million people compared to 480,000 civil servants. He promised an industrial park in Namasagali if assured of land.<\/p>\n\n\n\n

\u201cIndustrial jobs currently triple those of the government. Therefore, if you assure me of land, an industrial park will come to Namasagali as requested,\u201d he said.\u201cThese Americans have come here to support this work. Now all these other foreigners should know there is ancient knowledge here, and this knowledge can help the whole world. Regarding cassava, all these are gold mines because they are needed in the world. This is all wealth. But Africans are sleeping” he said.<\/p>\n\n\n\n

The President also highlighted the importance of industrialisation, noting that industries employ 1.3 million people compared to 480,000 civil servants.<\/p>\n\n\n\n

Dr. Magoola explained that nearly 99 percent of starch and other ingredients for tablet and capsule production are imported, making African pharmaceuticals expensive.<\/p>\n\n\n\n

\u201cWe are among the first companies in Africa to manufacture our own pharmaceutical ingredients…The facility aims to make quality medicines affordable for Ugandans and Africans, creating jobs and driving industrial growth,\u201d Dr. Magoola said.<\/p>\n\n\n\n

The starch plant, represents the first phase of the ambitious Dei Group Advanced Agro-processing Park, an industrial zone designed to supply locally manufactured excipients and active pharmaceutical ingredients, or APIs, to the company\u2019s drug manufacturing complex in Matugga, and also for export to regional and international markets.<\/p>\n\n\n\n

Dr Magoola explained that nearly 99 percent of starch and other ingredients for tablet and capsule production are imported, making African pharmaceuticals expensive.<\/p>\n\n\n\n

\u201cWe are among the first companies in Africa to manufacture our own pharmaceutical ingredients\u2026The facility aims to make quality medicines affordable for Ugandans and Africans, creating jobs and driving industrial growth,\u201d Dr Magoola said.The plant is expected to open a stable market for farmers in Busoga, Bukedi, Lango, and Teso sub-regions while reducing dependence on imported inputs.<\/p>\n\n\n\n

The commissioning occurred during President Museveni\u2019s re-election campaign in Kamuli District, attended by the First Lady Janet Museveni and other leaders.<\/p>\n\n\n\n

The president on the same day also commissioned the Dei Group\u2019s Organic Fertilizer Plant in Nansololo, Kamuli, part of the park in which Dr. Magoola, revealed the group intents to invest upto USD 10 billion in the next 10 years.<\/p>\n\n\n\n

The company strategically chose Namasagali for its geography and logistics.<\/p>\n\n\n\n

Located along the banks of the River Nile and near Lake Kyoga, the site easily connects to major cassava-growing regions, including Northern Uganda, Teso, Busoga and even parts of the Democratic Republic of Congo. Dei Biopharma has already registered more than 3,000 farmers and distributed Nilocus-1, a high-yield cassava variety developed by Ugandan crop scientists.<\/p>\n\n\n\n

Magoola said the shift to cassava would significantly improve farmer incomes, projecting that a cassava farmer could earn roughly triple what a sugarcane farmer earns on the same piece of land due to the crop\u2019s shorter growing cycle and higher returns per kilogram.<\/p>\n\n\n\n

While pharmaceutical-grade starch is the flagship product, the plant\u2019s applications stretch into broader industrial sectors.<\/p>\n\n\n\n

The facility is now producing glucose, maltose, or malt sugar, and two grades of fructose, key ingredients in beverage, food and drug manufacturing. Magoola revealed the company is starting with five products, but plans to eventually extract more than 100 derivatives from cassava, maize and potatoes, including Sarbitol, marnitol and dextrose.<\/p>\n\n\n\n

The facility is equipped with technology to modify starch for specialized uses and to produce vitamin C and other sugar derivatives critical to pharmaceutical production. Once approved by the U.S. Food and Drug Administration, Dei Biopharma expects to export its pharmaceutical-grade starch and intermediates to markets across Africa and the Global South.<\/p>\n\n\n\n

Dr. Magoola also emphasized that cassava offers dual benefits \u2014 both food and income \u2014 which helps address the food deficit created by the over-reliance on sugarcane in Busoga.<\/p>\n\n\n\n

The starch factory is one component of Dei Biopharma\u2019s broader agro-industrial blueprint on its 5,000-acre estate. The fully integrated hub will include the organic fertilizer plant producing organic inputs from animal waste, and a biotechnology complex for veterinary vaccines, including a Foot and Mouth Disease vaccine facility with a capacity for 100 million doses annually.<\/p>\n\n\n\n

By establishing an end-to-end manufacturing chain \u2014 from the farm to the finished pharmaceutical product \u2014 Dei Biopharma aims to position Uganda as a regional center for biopharmaceutical innovation.<\/p>\n\n\n\n

The $50 million investment is part of a larger $10 billion, 10-year plan to transform the Busoga region into a regional biotech and agro-industrial hub.<\/p>\n\n\n\n

The company\u2019s Matugga facility, partly operational, is designed to manufacture a range of essential medicines, from intravenous fluids to oncology drugs.<\/p>\n\n\n\n

Dr. Magoola said the addition of the Namasagali starch plant completes a key part of the supply chain, ensuring raw materials are locally sourced, costs are reduced and production becomes globally competitive.<\/p>\n\n\n\n

\u201cThe ultimate goal,\u201d he emphasized, \u201cis to make quality medicines affordable to every Ugandan and every African.\u201d<\/p>\n\n\n\n

On the same day, Dr. Magoola announced plans to establish a 1,000-bed specialist hospital within the park, dedicated to treating sickle cell disease, cancers and rare genetic disorders.<\/p>\n\n\n\n

The move seeks to redefine access to advanced therapies for millions of Africans. Dr. Magoola said the new hospital would provide clinical treatment using advanced gene and cell therapies, aiming to cut the cost of curative treatments like Lyfgenia and Casgevy \u2014 currently priced at over $2 million per dose internationally \u2014 by 99 percent. Dei Biopharma plans to use its intellectual property and Uganda\u2019s status under the WTO\u2019s TRIPS provisions for least developed countries to manufacture approved treatments locally, projecting the cost of a full sickle cell cure could fall to between $10,000 and $50,000.<\/p>\n\n\n\n

Inside the $10 Billion Dei BioPharma Vision to Revolutionise Sickle Cell, Cancer Treatments and Biotech Innovation in Uganda<\/p>\n\n\n\n

The Dei Group, owners of iconic Ugandan biotech firm, Dei BioPharma Ltd has embarked on plans to establish a 1,000-bed specialist hospital in Kamuli District dedicated to the treatment and research of sickle cell disease, cancers and rare genetic disorders\u2014 a move that could redefine access to advanced therapies for millions of Africans living with the inherited blood disorder.<\/p>\n\n\n\n

The proposed facility will be located inside the company\u2019s 5,000-acre Advanced Agro-Processing and Biotech Park in Namasagali, Kamuli.<\/p>\n\n\n\n

It marks the next phase in Dei Biopharma\u2019s broader biotechnology investment plan \u2014 one that seeks to position Uganda as a continental hub for pharmaceutical innovation, raw material production, and gene therapy research.<\/p>\n\n\n\n

According to the Founder and Managing Director Dr. Matthias Magoola, the new facility will provide clinical treatment for sickle cell and other rare diseases using advanced gene and cell therapies. \u201cWe are setting up a 1,000-bed hospital to treat sickle-cell disease and rare conditions,\u201d he said. \u201cOur goal is to cut the cost of these treatments by 99 percent and make them accessible to Africans who have long been priced out of life-saving innovations.\u201d<\/p>\n\n\n\n

Sickle cell disease (SCD) remains one of the most pressing yet underfunded public health challenges in Africa. While gene-editing breakthroughs such as Lyfgenia and Casgevy \u2014 both approved by the U.S. Food and Drug Administration (FDA) \u2014 have offered hope to patients globally, their staggering price tags make them unattainable for most.<\/p>\n\n\n\n

Lyfgenia costs about USD 3.1 million per dose, while Casgevy is priced at USD 2.2 million.<\/p>\n\n\n\n

\u201cThese are single-dose, curative treatments,\u201d Dr. Magoola explained, \u201cbut they remain beyond reach for the very populations most affected. Africa accounts for 80 percent of global sickle cell cases, yet less than one percent of those who need treatment can access it. In Uganda alone, 80 percent of children born with sickle cell don\u2019t live past the age of five.\u201d<\/p>\n\n\n\n

The World Health Organization estimates that Uganda ranks fifth globally in sickle cell burden, following Nigeria, India, the Democratic Republic of Congo, and Tanzania.<\/p>\n\n\n\n

For Dei Biopharma, the Kamuli facility represents both a humanitarian and scientific response to this inequity.<\/p>\n\n\n\n

Dei Biopharma plans to use its intellectual property portfolio \u2014 and the capabilities of its flagship biotech firm already valued at over USD 5 billion \u2014 and its status under the WTO\u2019s TRIPS (Trade-Related Aspects of Intellectual Property Rights) provisions for least developed countries to manufacture approved treatments locally without infringing international patent law.<\/p>\n\n\n\n

\u201cBecause we are a least-developed country, TRIPS allows us to produce these medicines legally,\u201d Dr. Magoola said. \u201cWe already have the technology for Lyfgenia and are developing our own treatment for sickle cell. The approval process for our version will take time, so our first priority is to make existing therapies available faster and morePresident Museveni praised Dr. Magoola for his resilience and innovation, sharply criticizing individuals who had previously frustrated the scientist\u2019s efforts.<\/p>\n\n\n\n

\u201cI want to congratulate Magoola as a very innovative young person,\u201d President Museveni said.<\/p>\n\n\n\n

\u201cAfricans don\u2019t like innovation. They are used to sleeping. They don\u2019t want new things. Africans need to critique themselves and support new individuals with innovative ideas because I know young people can have very good ideas. Even when I started fighting, some people thought I was mad,\u201d H.E. Museveni added, saying that Uganda\u2019s indigenous knowledge, long overlooked, was increasingly proving its global value.<\/p>\n\n\n\n

\u201cThese Americans have come here to support this work. Now all these other foreigners should know there is ancient knowledge here, and this knowledge can help the whole world. Regarding cassava, all these are gold mines because they are needed in the world. This is all wealth. But Africans are sleeping.\u201d affordably.\u201d<\/p>\n\n\n\n

By localising production, Dei Biopharma projects that the cost of a full sickle cell cure could fall to between USD 10,000 and USD 50,000 \u2014 a reduction of more than 95 percent compared to current international prices.<\/p>\n\n\n\n

Building a Biotech Ecosystem in Busoga:<\/strong><\/p>\n\n\n\n

The Kamuli complex forms part of a USD 10 billion ten-year investment plan to transform Busoga into a regional biotech and agro-industrial hub. Beyond the sickle cell hospital, the company is constructing a starch manufacturing plant with a daily processing capacity of 500 metric tons of cassava, and a Foot and Mouth Disease vaccine facility capable of producing up to 100 million doses per year.<\/p>\n\n\n\n

The broader ecosystem, dubbed the Dei Group Advanced Agro-Processing Park, will integrate the production of active pharmaceutical ingredients (APIs), excipients, and biotechnology derivatives from cassava, maize, and other local crops. \u201cWe\u2019re creating an advanced agro-industrial ecosystem \u2014 not just processing raw material, but extracting high-value components used in global drug manufacture,\u201d Dr. Magoola said.<\/p>\n\n\n\n

Uganda leading Africa\u2019s Innovation Growth Profile:<\/strong><\/p>\n\n\n\n

The company has filed more than 100 patent applications across pharmaceuticals, biotech, and advanced materials \u2014 part of a vision to elevate Africa\u2019s global innovation standing.<\/p>\n\n\n\n

\u201cIn the West, you find single companies valued higher than Africa\u2019s GDP,\u201d Dr. Magoola observed. \u201cThat is because we have been low on innovation and patents. What we are doing will change that. Through science, Africa is going to rise.\u201d<\/p>\n\n\n\n

The group plans to list on the Uganda Securities Exchange next year as part of its expansion drive and expects its valuation to grow exponentially as production scales up across its 30 manufacturing lines.<\/p>\n\n\n\n

\u201cThis is not just for Uganda,\u201d Dr. Magoola concluded. \u201cIt\u2019s for Africa as a whole. For the first time, we will be making our own excipients, APIs, and vaccines to global standards. So I invite everybody to join us on November 20, as we welcome President7 Museveni to commission the Starch Plant.\u201d<\/p>\n\n\n\n

Editor :msserwanga@gmail.com<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

By Our Reporters in Kamuli President Yoweri Museveni on November 20, 2025, commissioned a $50 million (Shs180.49 billion) starch factory<\/p>\n","protected":false},"author":1,"featured_media":15983,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[65],"tags":[],"class_list":["post-15982","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2025\/11\/20251121_132512-750x375-1.jpg","jetpack-related-posts":[{"id":10485,"url":"https:\/\/prowebinhost.com\/anzu\/the-late-dr-kazungu-to-be-accorded-official-burial-president-museveni\/","url_meta":{"origin":15982,"position":0},"title":"The Late Dr. Kazungu To Be Accorded Official Burial-President Museveni","author":"UgandaUpdate","date":"November 9, 2023","format":false,"excerpt":"President Yoweri Museveni has granted an official burial to fallen former minister, diplomat, educationist and elder, Dr. David Kazungu, the Minister of the Presidency Milly Bbalanda ,has announced . Babalanda added ,\"The N.O.C and family will issue a detailed burial program tomorrow. Sympathies to the Kazungu family.\" The late David\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/prowebinhost.com\/anzu\/category\/national-news\/"},"img":{"alt_text":"","src":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2023\/11\/Dr.-Kazungu.jpg","width":350,"height":200,"srcset":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2023\/11\/Dr.-Kazungu.jpg 1x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2023\/11\/Dr.-Kazungu.jpg 1.5x"},"classes":[]},{"id":2598,"url":"https:\/\/prowebinhost.com\/anzu\/museveni-commissions-isimba-bujagali-interconnection-bridge-to-boost-trade\/","url_meta":{"origin":15982,"position":1},"title":"MUSEVENI COMMISSIONS ISIMBA-BUJAGALI INTERCONNECTION BRIDGE TO BOOST TRADE","author":"UgandaUpdate","date":"January 8, 2021","format":false,"excerpt":"President Yoweri Museveni flanked by Speaker of Parliament Rebecca Kadaga has commissioned the Isimba -Bujagali interconnection bridge that will reduce the travelling lead times and boost trade in Eastern Uganda. Speaker Kadaga thanked the President and NRM government for continuing to finance and support development projects across the country saying\u2026","rel":"","context":"In "National Development"","block_context":{"text":"National Development","link":"https:\/\/prowebinhost.com\/anzu\/category\/national-development\/"},"img":{"alt_text":"","src":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/01\/m7-isimba.jpg","width":350,"height":200,"srcset":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/01\/m7-isimba.jpg 1x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/01\/m7-isimba.jpg 1.5x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/01\/m7-isimba.jpg 2x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/01\/m7-isimba.jpg 3x"},"classes":[]},{"id":3269,"url":"https:\/\/prowebinhost.com\/anzu\/nrms-cec-to-send-two-names-for-its-parliamentary-caucus-to-elect-speaker-of-11th-parliament-as-kadaga-is-sworn-as-kamuli-woman-mp\/","url_meta":{"origin":15982,"position":2},"title":"NRM\u2019s CEC TO SEND TWO NAMES FOR IT\u2019S PARLIAMENTARY CAUCUS TO ELECT SPEAKER OF 11th PARLIAMENT ,AS KADAGA IS SWORN AS KAMULI WOMAN MP","author":"UgandaUpdate","date":"May 18, 2021","format":false,"excerpt":"NRM party caucus to determine next SpeakerSpeaker to be elected at Kololo grounds on May 24th,2021 The NRM Central Executive Committee\u00a0 (CEC) has resolved to send two names to its parliamentary caucus to elect the Speaker of the 11th Parliament . The NRM CEC which sat at State House Entebbe\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/prowebinhost.com\/anzu\/category\/national-news\/"},"img":{"alt_text":"","src":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/05\/kada.jpg","width":350,"height":200,"srcset":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/05\/kada.jpg 1x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/05\/kada.jpg 1.5x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2021\/05\/kada.jpg 2x"},"classes":[]},{"id":12899,"url":"https:\/\/prowebinhost.com\/anzu\/museveni-kadaga-pay-tribute-at-fr-grimes-burial\/","url_meta":{"origin":15982,"position":3},"title":"Museveni, Kadaga Pay Tribute At Fr. Grimes Burial","author":"UgandaUpdate","date":"September 29, 2024","format":false,"excerpt":"President Yoweri Museveni has eulogized Fr. Darmian Grimes as a selfless man who strived for the betterment of others at the expense of his wellbeing. In a message read by Businessman and old student, Patrick Bitature at the burial of Grimes at Namasagali on Saturday, Museveni noted that, Grimes\u2019s act\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/prowebinhost.com\/anzu\/category\/national-news\/"},"img":{"alt_text":"","src":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2024\/09\/Fr.-Grimes.jpg","width":350,"height":200,"srcset":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2024\/09\/Fr.-Grimes.jpg 1x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2024\/09\/Fr.-Grimes.jpg 1.5x"},"classes":[]},{"id":13617,"url":"https:\/\/prowebinhost.com\/anzu\/president-museveni-invites-investors-to-uganda-and-africa-at-the-abu-dhabi-summit\/","url_meta":{"origin":15982,"position":4},"title":"President Museveni Invites Investors To Uganda And Africa At The Abu Dhabi Summit","author":"UgandaUpdate","date":"January 16, 2025","format":false,"excerpt":"President Yoweri Museveni, on a working visit in Abu Dhabi , has called on investors globally to set up investments in Uganda beacuse of their fast grpwing economies. He said that Uganda\u2019s economy which is growing at a fast rate and that of other African countries need a stimulant in\u2026","rel":"","context":"In "National News"","block_context":{"text":"National News","link":"https:\/\/prowebinhost.com\/anzu\/category\/national-news\/"},"img":{"alt_text":"","src":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2025\/01\/Screenshot_20250115_192932_Gmail-750x375-1.jpg","width":350,"height":200,"srcset":"https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2025\/01\/Screenshot_20250115_192932_Gmail-750x375-1.jpg 1x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2025\/01\/Screenshot_20250115_192932_Gmail-750x375-1.jpg 1.5x, https:\/\/prowebinhost.com\/anzu\/wp-content\/uploads\/2025\/01\/Screenshot_20250115_192932_Gmail-750x375-1.jpg 2x"},"classes":[]}],"jetpack_shortlink":"https:\/\/wp.me\/pc0aOV-49M","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/posts\/15982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/comments?post=15982"}],"version-history":[{"count":1,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/posts\/15982\/revisions"}],"predecessor-version":[{"id":15985,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/posts\/15982\/revisions\/15985"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/media\/15983"}],"wp:attachment":[{"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/media?parent=15982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/categories?post=15982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prowebinhost.com\/anzu\/wp-json\/wp\/v2\/tags?post=15982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}